Google

Layer Health is a technology company specializing in AI-driven healthcare information solutions. It develops an AI-powered platform designed to help healthcare providers extract valuable insights from patient data, enabling them to make informed decisions, enhance patient care, and improve operational efficiency. The platform focuses on processing unstructured data from clinical, administrative, and research sources, transforming it into actionable insights.

Allara Health is a healthcare provider specializing in virtual care for women facing complex, chronic health conditions, particularly polycystic ovary syndrome (PCOS). The company offers a comprehensive program that connects patients with medical providers and registered dietitians through virtual appointments. Allara's services include holistic care, diagnostic testing, and prescriptions, along with personalized guidance on dietary and lifestyle changes. By leveraging technology, the platform enables women to efficiently manage their health, allowing for improved tracking and treatment of their conditions.

Clear Labs is a biotechnology company specializing in next-generation sequencing and data analytics for infectious disease surveillance and food safety testing. Its platforms, Clear Dx™ and Clear Safety™, enable rapid identification of pathogens, supporting public health initiatives and enhancing safety across various sectors.

Prudentia Sciences is a technology company that provides an AI-driven platform for asset diligence and valuation in drug development. Its platform aims to reduce investment risks by enabling investors and biopharma clients to effectively evaluate and showcase the value of drug assets during portfolio strategy planning and dealmaking, ultimately accelerating drug pipelines and maximizing returns.

Cala Health is a bioelectronic medicine company that develops wearable neuromodulation therapies for chronic diseases. Its primary product, Cala Trio therapy, is a non-invasive prescription treatment for essential tremor.

Synapticure specializes in providing remote, disease-specific neurological care for patients with neurodegenerative diseases such as dementia, Parkinson's, and ALS across the United States. Founded by patients, they offer on-demand neurologists, speech-language therapists, round-the-clock care coordination, and support services tailored to each patient's needs.

Vitara Biomedical is focused on developing a therapeutic platform designed to support premature infants. The company draws inspiration from natural physiological processes to improve neonatal care, aiming to enhance the quality of life for these vulnerable newborns. By addressing the unique challenges faced by premature infants, Vitara Biomedical seeks to reduce mortality rates and associated health complications, ultimately providing a foundation for a healthier future for both infants and their families.

Metsera is a clinical-stage biopharmaceutical company specializing in developing innovative therapies for obesity and metabolic conditions. It focuses on advancing oral and injectable treatments, integrating proprietary health technology tools for personalized care.

Diverge Health equips primary care practices with tools and support to deliver quality healthcare services to underserved patient populations.

Jacaranda Health is a medical services provider in Kenya, specializing in maternal and child health. It operates clinics in underserved, peri-urban areas, offering high-quality, affordable care, including maternity services, general healthcare, and nursing mentorship. Jacaranda's services are designed to be patient-centered and cost a fifth of what's charged by other private hospitals. Notably, the company has achieved a zero maternal mortality rate, significantly lower than Kenya's national average of 400 per 100,000 births. Additionally, Jacaranda engages in research and innovation to improve its services and develop new tools for low-income women.

PeopleOne Health delivers advanced healthcare solutions that integrate treatment and prevention, resulting in substantial cost savings for employers (up to 30%) and improved employee recruitment/retention. Employees enjoy complimentary access to top-tier doctors and healthcare professionals, with a focus on comprehensive primary care and mental health support.

Infinitus Systems automates phone calls in healthcare using AI. It streamlines administrative tasks like insurance eligibility checks, improving efficiency, reducing costs, and enhancing patient care.

Ubie, Inc. is a Tokyo-based company founded in 2017 that specializes in developing artificial intelligence-powered healthcare solutions. Its core offering is an AI-driven symptom checker that generates personalized evaluation reports for patients. Through a brief questionnaire that customizes its inquiries based on factors such as biological sex, age, medical history, and lifestyle choices, the tool aims to assist users in understanding potential causes of their symptoms. In addition to providing patients with detailed reports, Ubie also supplies physicians with patient summaries and predictive diagnoses to enhance clinical decision-making.

Nym Health Inc., established in 2017 and headquartered in Boston, Massachusetts, specializes in medical coding technology for healthcare facilities. Its core product, Nym, is an autonomous coding solution that streamlines revenue cycle management. Nym reduces denials and operational expenses by directly billing and accurately assigning medical charge codes from patient charts, improving payment cycles and audit-readiness. It identifies relevant clinical aspects, assigns codes, and provides an audit trail explaining its coding decisions. With a research and development center in Tel Aviv-Yafo, Israel, Nym enables healthcare providers to enhance coding quality, lower costs, and focus more on patient care.

PGxAI is an AI-powered pharmacogenetics platform enabling precision medicine by applying proprietary algorithms to real-world data to inform drug choice, dosing personalization, and drug-drug interaction identification. It partners with InterSystems, a major patient-data provider, and uses tools such as VectorSearch and GenAI to access extensive real-world data. The platform supports clinical decision-making, aims to improve patient outcomes, accelerate drug development, and reduce costs through targeted patient stratification and real-time analytics. It delivers rapid, actionable reports via seamless LIMS integration, enabling healthcare organizations to implement personalized medicine at scale.

Pelage Pharma delivers a clinically tested treatment for both men and women battling the emotional pain or social stigma of hair loss. Its non-invasive, topical small molecule drug platform activates hair follicle stem cells and stimulates robust hair growth.

Santa Ana Bio is a biotechnology company specializing in the development of precision immunology therapies for autoimmune diseases. It employs advanced multi-omics platforms and antibody engineering techniques to design targeted biologics, aiming to improve patient outcomes and quality of life.

BridgeBio Oncology Therapeutics is a biopharmaceutical company specializing in the development of precision oncology therapeutics. It focuses on targeting RAS-dependent cancers, leveraging a profound understanding of RAS signaling biology to create drugs that selectively inhibit RAS-driven PI3K activation and a wide spectrum of KRAS mutants. The company aims to provide patients with tailored treatments that address both active and inactive cancer-driving states.

AccuLine is a digital health company dedicated to early detection of coronary artery disease. It develops CORA, a smart, accurate, and user-friendly exam designed to replace traditional ECG stress tests, enabling healthcare providers to prevent heart attacks more effectively.

Cerevance develops novel therapeutics for neurological disorders such as Alzheimer's disease, Parkinson's disease, and other chronic neurodegenerative conditions. It uses a proprietary platform to profile specific brain cell types in human tissue samples, enabling the identification of promising targets for new treatments.

Metsera is a clinical-stage biopharmaceutical company specializing in developing innovative therapies for obesity and metabolic conditions. It focuses on advancing oral and injectable treatments, integrating proprietary health technology tools for personalized care.

Pelage Pharma delivers a clinically tested treatment for both men and women battling the emotional pain or social stigma of hair loss. Its non-invasive, topical small molecule drug platform activates hair follicle stem cells and stimulates robust hair growth.

Fabric is a health tech company that enables healthcare providers to deliver faster, higher quality, and more accessible care while reducing costs via consumer-grade patient experiences that automate workflows for staff.

Areteia Therapeutics is a biotechnology company focused on developing oral therapies for eosinophilic asthma to improve disease control. The company was spun out of Knopp and is advancing an oral drug designed to inhibit eosinophil maturation, aiming to reduce inflammation and alleviate symptoms of severe asthma. Phase 2 data from its program indicated the oral candidate lowers blood eosinophil counts, a marker associated with better lung function. By pursuing an oral, non-injectable treatment option, Areteia seeks to offer a convenient alternative to injectable therapies and broaden access for asthma patients. The company’s work centers on targeting eosinophil-related pathways to enhance asthma management and patient quality of life.

Accent Therapeutics, Inc. is a biopharmaceutical company focused on developing small molecule therapies for oncology, utilizing the emerging field of epitranscriptomics. Founded in 2017 and headquartered in Lexington, Massachusetts, the company explores the post-transcriptional chemical modifications of RNA, which play a crucial role in regulating proteins essential for cellular growth and differentiation. By precisely targeting cancer-associated RNA-modifying proteins, Accent Therapeutics aims to innovate and deliver transformative therapies that can significantly improve patient outcomes in cancer treatment.

Comanche is a biopharmaceutical company developing an investigational siRNA medicine for preterm preeclampsia. Its mission is to provide safe, effective, evidence-based, and affordable therapies for treating life-threatening complications of pregnancy.

Moonwalk Biosciences is a genomic medicine startup focused on developing precision epigenetic therapeutics. The company specializes in creating a profiling and engineering technology platform that leverages advanced artificial intelligence predictions to offer a comprehensive view of the epigenome in both health and disease states. This innovative approach aims to revolutionize therapy discovery and development, enabling healthcare providers to reprogram cells back to their healthy state.

Onward Assist develops an advanced cancer prognostics and predictive healthcare analytics platform that supports oncologists and pathologists in diagnosing and treating cancer. The platform uses machine learning and computer vision to analyze histopathology slides, radiology data, and other tumor information to provide automated diagnostics, prognosis, and treatment decision support, aiming to improve accuracy, efficiency, and outcomes. Its PathAssist product combines AI-driven ML and computer vision tools for automated diagnostics in histopathology with pathology workflow and telepathology capabilities, plus low-cost slide digitisation hardware to streamline workflows. The platform also analyzes tumor and surrounding tissue to predict cancer cell behavior, enabling deeper insights into tumor biology and more informed prognosis and treatment protocols. Overall, Onward Assist seeks to enhance diagnostic accuracy and decision-making in cancer care by integrating predictive analytics with practical workflow solutions for clinicians.

Seismic Therapeutic is a biotechnology company focused on advancing immunology drug development through the integration of machine learning in the biologics discovery process. Utilizing its proprietary IMPACT™ platform, Seismic Therapeutic addresses critical challenges in the development of biologics by combining machine learning with structural biology, protein engineering, and translational immunology. This innovative approach aims to create optimized therapies for patients more efficiently. The company is developing a pipeline of biologics specifically targeting adaptive immune system dysregulation to treat various autoimmune diseases.

YMCA of Metropolitan Dallas is a religious organization that focuses on youth development, healthy living, and social services. The organization was founded in 1885 and is based in Irving, Texas. YMCA of Metropolitan Dallas operates as a subsidiary of Ymca Of Greater Pittsburgh.

Layer Health is a technology company specializing in AI-driven healthcare information solutions. It develops an AI-powered platform designed to help healthcare providers extract valuable insights from patient data, enabling them to make informed decisions, enhance patient care, and improve operational efficiency. The platform focuses on processing unstructured data from clinical, administrative, and research sources, transforming it into actionable insights.

Signos is a health technology company focused on addressing the obesity epidemic by promoting healthy habits and stabilizing glucose levels through innovative solutions. The company offers a weight loss application that leverages continuous glucose monitoring in conjunction with an AI-enhanced platform. This combination provides users with real-time data and personalized recommendations for meals and exercises tailored to their unique metabolic responses. By enabling individuals to better understand their body's reactions to food, Signos aims to facilitate effective weight loss and foster sustainable health improvements. With a significant portion of the American population facing weight-related challenges, Signos presents a modern approach to support users on their journey towards healthier living.

Wadhwani AI is a non-profit research institute based in India, dedicated to developing artificial intelligence solutions for social good. Its focus areas include health, agriculture, financial inclusion, infrastructure, and education. The organization works directly with local communities and stakeholders, using its global perspective to create applicable solutions worldwide. Wadhwani AI measures success by the impact it catalyzes, focusing on areas such as early pest warning systems, cotton farming, maternal and child health, anthropometry, and tuberculosis eradication.

Allara Health is a healthcare provider specializing in virtual care for women facing complex, chronic health conditions, particularly polycystic ovary syndrome (PCOS). The company offers a comprehensive program that connects patients with medical providers and registered dietitians through virtual appointments. Allara's services include holistic care, diagnostic testing, and prescriptions, along with personalized guidance on dietary and lifestyle changes. By leveraging technology, the platform enables women to efficiently manage their health, allowing for improved tracking and treatment of their conditions.

Causal Foundry is a personalization to solve the greatest challenges in healthcare and medicine.

RAD-AID International is dedicated to improve radiology services in the developing world and poor areas.

IDinsight with Reach Digital Health developed a natural language-enabled question-and-answer service for pregnant moms that delivers responses to questions as well as important health information.

Jacaranda Health is a medical services provider in Kenya, specializing in maternal and child health. It operates clinics in underserved, peri-urban areas, offering high-quality, affordable care, including maternity services, general healthcare, and nursing mentorship. Jacaranda's services are designed to be patient-centered and cost a fifth of what's charged by other private hospitals. Notably, the company has achieved a zero maternal mortality rate, significantly lower than Kenya's national average of 400 per 100,000 births. Additionally, Jacaranda engages in research and innovation to improve its services and develop new tools for low-income women.

ROME Therapeutics, Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on developing innovative therapies for cancer and autoimmune diseases. Founded in 2019, the company utilizes the repeatome, which encompasses extensive segments of genetic material previously regarded as "junk DNA," to identify new drug targets and advance multiple discovery programs. ROME Therapeutics has assembled a team of experts in oncology, immunology, virology, and machine learning to drive its research and development efforts, aiming to harness this uncharted area of biology for effective treatments. Through its work, ROME seeks to provide healthcare professionals with powerful new options for addressing complex medical challenges.

Nimbus Therapeutics, LLC is a biotechnology company based in Cambridge, Massachusetts, focused on discovering and developing innovative medicines for serious diseases, including metabolic disorders, cancer, and immune-inflammatory conditions. Founded in 2009, the company utilizes a computational technology-driven approach to advance a pipeline of novel small-molecule therapeutics. Nimbus Therapeutics specializes in designing allosteric inhibitors, notably targeting Acetyl-CoA Carboxylase for conditions such as non-alcoholic steatohepatitis and hepatocellular carcinoma. The company has established strategic partnerships with organizations like Charles River Laboratories and Celgene Corporation to enhance its drug development efforts. In March 2015, Nimbus Discovery rebranded itself as Nimbus Therapeutics to better reflect its transition into a clinical-stage enterprise.

Caraway is a digital healthcare company focused on providing integrated mental, reproductive, and physical healthcare services specifically for college women. Designed with input from students, Caraway delivers a personalized and equitable care solution that addresses the unique needs and concerns of women during a crucial developmental period. The platform emphasizes accessible and compassionate healthcare, recognizing the growing demand for mental health resources and the persistent inequities in women's health. By offering trusted and holistic care, Caraway empowers college students to effectively manage their health in a complex and often challenging healthcare landscape.

Delve Bio is a biotechnology company that provides molecular insights to guide precision patient care, offering pathogen-agnostic and unbiased detection of neuro-infectious pathogens in cerebrospinal fluid to enable laboratories and clinicians to diagnose routine and rare infectious diseases with actionable results.

Bitterroot Bio specializes in developing innovative therapies for cardiovascular disease by harnessing the power of immunotherapy.

Comanche is a biopharmaceutical company developing an investigational siRNA medicine for preterm preeclampsia. Its mission is to provide safe, effective, evidence-based, and affordable therapies for treating life-threatening complications of pregnancy.

Fabric is a health tech company that enables healthcare providers to deliver faster, higher quality, and more accessible care while reducing costs via consumer-grade patient experiences that automate workflows for staff.

Founded in 2019, Clever Care Health Plan specializes in Medicare Advantage plans that integrate Eastern and Western medicine. It offers culturally sensitive healthcare solutions, including acupuncture, herbal remedies, tai chi, qi gong, cupping, and moxibustion treatments. The company connects members to diverse networks of hospitals, doctors, brokers, and member advocates.

MedTourEasy, a global healthcare company, provides you the informational resources needed to evaluate your global options. MedTourEasy provides analytical solutions to our partner healthcare providers globally.

Chroma Medicine is a genomic medicine company founded in 2021 and based in Cambridge, Massachusetts, specializing in epigenetic editing. The company is pioneering a new class of genomic therapies aimed at revolutionizing the treatment of genetically driven diseases. By utilizing epigenetics, which is the natural mechanism for gene regulation, Chroma Medicine develops programmable epigenetic editors that target specific genes and modulate chromatin conformation. This innovative approach enables healthcare providers to achieve precise control of gene expression, offering a promising therapeutic option for conditions linked to genetic anomalies.

Santa Ana Bio is a biotechnology company specializing in the development of precision immunology therapies for autoimmune diseases. It employs advanced multi-omics platforms and antibody engineering techniques to design targeted biologics, aiming to improve patient outcomes and quality of life.

Thatch is a digital platform designed to streamline employee healthcare management for businesses. It offers an AI-driven assistant, ThatchBot, which provides round-the-clock support for employees' healthcare queries and expense tracking. The platform enables companies to set personalized healthcare budgets for each employee, fostering tailored healthcare experiences and efficient benefits navigation.

Thatch is a digital platform designed to streamline employee healthcare management for businesses. It offers an AI-driven assistant, ThatchBot, which provides round-the-clock support for employees' healthcare queries and expense tracking. The platform enables companies to set personalized healthcare budgets for each employee, fostering tailored healthcare experiences and efficient benefits navigation.

Cerevance develops novel therapeutics for neurological disorders such as Alzheimer's disease, Parkinson's disease, and other chronic neurodegenerative conditions. It uses a proprietary platform to profile specific brain cell types in human tissue samples, enabling the identification of promising targets for new treatments.

Paradigm is rebuilding the clinical research ecosystem by developing a platform that allows all patients equitable access to trials while improving trial efficiency and lowering barriers to participation for healthcare providers. It is an innovative company that is dedicated to transforming the clinical research ecosystem. Their mission is to create a more accessible and equitable healthcare system by developing a platform that enables patients from diverse backgrounds to participate in clinical trials. Clinical trials are essential for testing and developing new drugs, therapies, and medical devices, but historically, they have been plagued by inefficiencies, barriers to access, and inequities in patient representation. Paradigm aims to solve these challenges by creating a platform that uses technology and data-driven insights to streamline the clinical trial process, making it more efficient, cost-effective, and inclusive. The Paradigm platform is designed to facilitate seamless communication and collaboration among all stakeholders involved in clinical research, including patients, healthcare providers, pharmaceutical companies, and regulatory agencies. By leveraging technology such as AI, machine learning, and predictive analytics, Paradigm can identify and match eligible patients to clinical trials, streamline the recruitment and enrollment process, and provide real-time data insights to all stakeholders. Overall, Paradigm's innovative approach to clinical research has the potential to revolutionize the healthcare industry by improving patient outcomes, reducing healthcare costs, and accelerating the development of new treatments and therapies.

Britto's Brainwaves is a healthcare company that emerges as a beacon for those seeking in-depth medical insights.

Wadhwani AI is a non-profit research institute based in India, dedicated to developing artificial intelligence solutions for social good. Its focus areas include health, agriculture, financial inclusion, infrastructure, and education. The organization works directly with local communities and stakeholders, using its global perspective to create applicable solutions worldwide. Wadhwani AI measures success by the impact it catalyzes, focusing on areas such as early pest warning systems, cotton farming, maternal and child health, anthropometry, and tuberculosis eradication.

The Indian Institute of Technology Madras is a public technical and research university. It offers undergraduate, postgraduate, and doctoral programs across various engineering, science, and humanities disciplines. The institute focuses on research and innovation, contributing to advancements in technology and education. It serves industries such as information technology, manufacturing, energy, and healthcare.

Galileo is a technology company based in New York, founded in 2014, specializing in healthcare solutions. The company offers a mobile application and online communication platform that enables medical professionals to provide comprehensive clinical care directly from their phones. This includes synchronous and asynchronous telecommunications technologies for connecting providers with patients. Galileo's services cater to diverse patient populations, offering high-touch, data-driven, multi-specialty longitudinal care over the phone, at home, and in various settings. The company is recognized by regional and national health plans, employers, and Fortune 500 companies as a leading solution for improving population health.

Founded in 2015, Carrick Therapeutics is a biopharmaceutical company based in Dublin, Ireland. It specializes in developing innovative cancer therapeutics that target molecular pathways driving aggressive and resistant forms of cancer, aiming to transform cancer treatment.

Contraline, Inc. is a biotechnology company based in Charlottesville, Virginia, focused on developing innovative male birth control solutions. The company is pioneering the first long-lasting, non-hormonal, and reversible contraceptive for men. Its primary product, Echo-V, is an ultrasound-visible polymer solution that is injected into the vas deferens, forming a polymer hydrogel device. This device functions as a semi-permeable membrane, effectively blocking sperm while allowing bodily fluids to pass through. Contraline also offers Vasintomy, a non-surgical procedure for the insertion of Echo-V, providing a cost-effective and accessible approach to male contraception. Incorporated in 2015, Contraline aims to transform the landscape of reproductive health for men.

Sound Life Sciences, Inc. is a Seattle-based company that specializes in developing clinically validated software for mobile phones and smart speakers aimed at detecting critical health conditions, such as overdose and cardiac arrest. Founded in 2018, the company employs a sonar-based, contactless respiratory monitoring system that can identify changes in breathing patterns, facilitating timely interventions in both chronic disease management and emergency situations. The software is designed to trigger emergency alarms in cases of respiratory failure, thereby enhancing patient safety. Sound Life Sciences is focused on obtaining FDA clearance through the 510(k) pathway, with applications extending to wellness and environmental sensing in various settings, including homes and mobile environments.

Pasito simplifies employee benefits enrollment through its intelligent platform. It uses advanced algorithms and data to provide personalized guidance for each individual, helping them make informed decisions about their HSA plans, supplemental medical insurance, voluntary insurance, and retirement accounts year-round.

ReflexAI empowers human support teams by providing scalable AI tools for advanced roleplay simulations and intelligent quality assurance, enhancing outcomes in every customer interaction.

Vitara Biomedical is focused on developing a therapeutic platform designed to support premature infants. The company draws inspiration from natural physiological processes to improve neonatal care, aiming to enhance the quality of life for these vulnerable newborns. By addressing the unique challenges faced by premature infants, Vitara Biomedical seeks to reduce mortality rates and associated health complications, ultimately providing a foundation for a healthier future for both infants and their families.

Verily is an Alphabet health technology company focused on research, care, and health financing to deliver on the promise of precision health and help people live healthier lives. We are uniquely positioned at the intersection of technology, data science, and healthcare to create tools to accelerate evidence generation, products to enable more personalized care, and approaches to make costs more predictable. For more information about Verily please visit verily.com. The company was founded in 2015 and is based in San Francisco, California, United States.

Kindbody is a comprehensive fertility clinic network and family-building benefits provider that offers a wide range of services aimed at improving access to healthcare for women. The company provides both virtual and in-person care, including fertility assessments, education, preservation, genetic testing, in vitro fertilization (IVF), donor and surrogacy services, and adoption. By partnering with employers, Kindbody delivers financial, medical, and emotional support to employees pursuing parenthood. The company serves more than 100 employers, covering over 2.4 million lives, while also providing direct fertility care through its network of signature clinics, mobile clinics, and partner clinics across the country. With a focus on affordability and accessibility, Kindbody employs modern technology to deliver holistic health and fertility services.

Fractyl Health Inc. is a medical technology company dedicated to developing innovative solutions for the treatment of metabolic diseases, particularly type 2 diabetes and obesity. The company specializes in a minimally invasive procedure known as Revita DMR, or duodenal mucosal resurfacing therapy, which rejuvenates the lining of the duodenum through hydrothermal ablation. This approach aims to remove excessive layers of the duodenal mucosa that accumulate due to unhealthy diets, thereby addressing the root causes of metabolic disorders. Founded in 2010 and based in Lexington, Massachusetts, Fractyl Health seeks to redefine the treatment landscape from chronic management to durable, disease-modifying therapies, ultimately enhancing patient health and reducing the burden on healthcare systems.

Vicinitas Therapeutics is a biotech startup that specializes in developing medicines that impact patient lives. Its vision is to use its proprietary Deubiquitinase Targeting Chimera (DUBTAC) platform to restore the levels of aberrantly degraded proteins that cause disease to confer therapeutic benefit.

Xilis, Inc. is a biotechnology company founded in 2019 and based in Chapel Hill, North Carolina. The company specializes in developing next-generation organoid technologies aimed at guiding precision therapy for cancer patients and enhancing drug discovery processes. Its flagship platform, XilisµO, facilitates rapid diagnostics, personalized drug screening, and the creation of scalable patient-derived models, which support high-throughput drug discovery. By enabling both physicians and pharmaceutical companies to conduct tailored drug screenings, Xilis aims to lower costs and improve treatment outcomes for cancer patients.

Areteia Therapeutics is a biotechnology company focused on developing oral therapies for eosinophilic asthma to improve disease control. The company was spun out of Knopp and is advancing an oral drug designed to inhibit eosinophil maturation, aiming to reduce inflammation and alleviate symptoms of severe asthma. Phase 2 data from its program indicated the oral candidate lowers blood eosinophil counts, a marker associated with better lung function. By pursuing an oral, non-injectable treatment option, Areteia seeks to offer a convenient alternative to injectable therapies and broaden access for asthma patients. The company’s work centers on targeting eosinophil-related pathways to enhance asthma management and patient quality of life.

Medallion is a San Francisco-based company founded in 2020 by Derek Lo, specializing in a network management platform tailored for the healthcare industry. The company offers an all-in-one solution for licensing, credentialing, and payer enrollment, aimed at simplifying the often cumbersome processes associated with healthcare paperwork. Its platform provides features such as primary source verification, continuing medical education tracking, and document management, enabling healthcare providers and telemedicine companies to minimize time spent on administrative tasks and focus more on patient care.

Sesame, Inc., operating as SesameCare, is a healthcare technology company founded in 2018 and based in New York, New York. The company has developed an innovative platform that enables users to book medical appointments and access healthcare services conveniently and affordably. By leveraging an AI-enabled marketplace, SesameCare eliminates the need for health insurance, fostering competition among healthcare providers based on quality, accessibility, and pricing. This approach allows the company to offer Americans high-quality medical care at significantly reduced costs. Additionally, Sesame is recognized as the official telehealth partner of Costco, further enhancing its reach and service offerings.

Nava is a health insurance brokerage based in New York, New York, dedicated to providing high-quality, affordable healthcare solutions to employers and their employees. The company offers a range of services that include healthcare tools, year-round employee advocacy, and continuous evaluation of healthcare plans. By leveraging these resources, Nava empowers clients to deliver essential benefits while simultaneously reducing overall plan costs. Its innovative approach aims to transform the employee benefits landscape through enhanced access and advocacy in healthcare.

Syrona Health is a digital health company focused on personalized gynecological care throughout various life stages, including menstrual health, fertility, parenthood, and menopause. It offers a virtual health support platform that integrates software and hardware to enhance gynecological health outcomes. The company's solutions address conditions such as endometriosis, polycystic ovary syndrome (PCOS), and gynecological cancers, enabling women to monitor their health independently. Syrona Health also provides at-home clinical testing and online counseling, allowing women to manage their gynecological health proactively without relying on lengthy clinic visits for diagnostics.

Zoozy is a mobile application that serves as a pet life assistant. It monitors activity and health data, calculates dietary needs, sends health alerts, and facilitates regular food delivery for pets.

Mirvie is a biotechnology company specializing in precise, non-invasive diagnostic tests for maternal-fetal health. Founded in 2018, the company aims to enhance pregnancy safety by providing actionable insights to families and enabling early intervention for potential complications.

Waltz Health is a company focused on innovating the pharmaceutical supply chain by developing technology-driven solutions for pricing, distribution, and prescription of medications. It collaborates with various partners, including consumers, payers, and pharmacies, to create smarter ways to manage prescription care. The company utilizes AI-driven marketplaces to reduce costs and offers consumer tools that enhance decision-making regarding healthcare. These tools provide users with better pricing, comprehensive information, and resources aimed at lowering expenses, empowering consumers, and enabling payers to effectively manage their pharmacy benefits. Through these efforts, Waltz Health strives to improve the overall experience and affordability of prescription medications.

Viz.ai, Inc. specializes in healthcare imaging software designed to enhance stroke care through the use of artificial intelligence. The company's flagship technology synchronizes treatment by reducing delays in patient care, enabling rapid identification of large vessel occlusion (LVO) strokes using advanced deep learning algorithms. Key offerings include Viz LVO, which alerts on-call stroke teams based on CT angiogram images, and Viz CTP, which analyzes CT perfusion images and generates critical parametric data. Additionally, Viz HUB facilitates communication among clinical teams to coordinate care efficiently, while Viz VIEW allows healthcare professionals to view imaging data on mobile devices. Founded in 2016 and headquartered in San Francisco, the company aims to transform healthcare delivery by improving the speed and accessibility of treatment for stroke patients.

Brightline, Inc. is a pediatric behavioral health care provider that focuses on supporting children and their families through innovative technology and integrated care. Established in 2019 and headquartered in Palo Alto, California, Brightline offers a range of services including behavioral therapy, psychiatry, medication support, speech-language therapy, and occupational therapy. The company emphasizes virtual behavioral health services and a collaborative care team to address the diverse needs of children at various developmental stages. Originally named Emilio Health, Inc., the company rebranded to Brightline in May 2020, reflecting its commitment to delivering accessible and comprehensive behavioral health solutions.

Elly Health Inc. specializes in developing audio companion software designed for patients, healthcare providers, and organizations. Founded in 2019 and headquartered in Los Angeles, California, the company offers Elly, an innovative empathetic audio companion specifically tailored for individuals managing chronic diseases. This technology aims to motivate and support patients by connecting them with expert advice and community contributions, thereby enhancing their healthcare experience. Elly Health Inc. stands out as a pioneer in the realm of empathetic digital health solutions.

Celsius Therapeutics, Inc. is a biotechnology company focused on developing precision medicines for patients suffering from cancer and autoimmune diseases. Founded in 2018 and based in Cambridge, Massachusetts, the company employs a multidisciplinary approach, integrating the expertise of scientists, computational biologists, and clinicians. Celsius Therapeutics utilizes advanced techniques such as single-cell genomic analysis and machine learning to identify and develop innovative therapeutic solutions. By leveraging these cutting-edge technologies, the company aims to create life-changing medicines that address unmet medical needs.

LifeMine Therapeutics, Inc. is a biotechnology company focused on the genomic discovery of new drug modalities derived from eukaryotic microbes, specifically fungi. Founded in 2016 and headquartered in Cambridge, Massachusetts, with an additional office in New York, it employs an integrated drug discovery platform that combines genomics, artificial intelligence, and synthetic biology. LifeMine’s Avatar-Rx platform utilizes high-throughput microbiology, data science, genome engineering, and automation technologies to identify novel gene-encoded molecules (GEMs) with specific biological functions. The company emphasizes chemoinformatic-assisted drug optimization and advanced chemical synthesis, enabling the progression of new product candidates into development. Founded by experts in the field, LifeMine Therapeutics aims to innovate medicine through its unique approach to leveraging the fungal biosphere.

Founded in 2017, Spotlight Therapeutics develops innovative therapeutics based on its targeted active gene editing platform. The company focuses on creating biologics tailored to specific cell populations, with initial programs in immuno-oncology, ophthalmology, and hematology.

DNAnexus, Inc. is a cloud-based provider of genome informatics and data management tools, primarily serving enterprises and organizations involved in genomic medicine. Founded in 2009 and headquartered in Mountain View, California, the company offers a platform that facilitates the analysis of raw sequencing data and the integration of genomic data with clinical information. Its suite of products includes MOSAIC Microbiome for collaborative research on the human microbiome, DNAnexus Apollo for clinico-genomic data exploration, and DNAnexus Titan for data analysis. Additionally, the DNAnexus Portals provide secure online workspaces for cross-disciplinary collaboration, while the Clinico-Genomic Data Solution addresses the need for disease-specific datasets through partnerships with healthcare providers. The company has established itself as a key player in the biopharmaceutical, diagnostic, and academic research sectors, enabling clients to tackle complex challenges in human health with enhanced security and scalability. DNAnexus also maintains a strategic alliance with WuXi NextCODE Genomics and has locations in San Francisco, London, and Prague.

Seismic Therapeutic is a biotechnology company focused on advancing immunology drug development through the integration of machine learning in the biologics discovery process. Utilizing its proprietary IMPACT™ platform, Seismic Therapeutic addresses critical challenges in the development of biologics by combining machine learning with structural biology, protein engineering, and translational immunology. This innovative approach aims to create optimized therapies for patients more efficiently. The company is developing a pipeline of biologics specifically targeting adaptive immune system dysregulation to treat various autoimmune diseases.

Synapticure specializes in providing remote, disease-specific neurological care for patients with neurodegenerative diseases such as dementia, Parkinson's, and ALS across the United States. Founded by patients, they offer on-demand neurologists, speech-language therapists, round-the-clock care coordination, and support services tailored to each patient's needs.

TenSixteen Bio is a biotechnology company dedicated to developing innovative therapeutics targeting various diseases. It leverages somatic mosaicism and clonal hematopoiesis (CHIP) to discover and advance treatments for age-related disorders.

Verana Health, Inc. is a digital health company based in San Francisco, California, that specializes in transforming healthcare data into actionable insights. Founded in 2008 and formerly known as Digisight Technologies, the company connects healthcare providers with patients through innovative solutions. Its flagship product, SightBook, is a mobile application that enables users to test their vision and share results with their physicians in real-time, facilitating timely appointments and treatments. Verana Health manages data from over 20,000 healthcare providers and 70 electronic health record systems, leveraging its AI-enhanced platform, VeraQ™, to create a robust healthcare data ecosystem. By utilizing advanced analytics on curated datasets, Verana Health supports life sciences partners in improving clinical research and enhancing patient care outcomes.

Found is dedicated to improving people’s overall wellbeing by making evidence-based weight loss accessible and affordable. The company was founded in 2019 and is headquartered in San Francisco, California, United States.

Founded in 2014, Quartet Health operates a cloud-based platform facilitating communication between medical providers and behavioral health specialists for improved patient care. The platform works with health plans and systems to provide actionable insights on behavioral health conditions, enhancing patient outcomes.

Ankyra is a biotech company focused on developing anchored immunotherapy to enhance cancer treatment. The company's innovative approach addresses the challenges associated with traditional cytokine therapeutics, which often face limitations due to widespread immune activation and toxicity when administered systemically. Ankyra utilizes its Anchored Immunotherapy Platform to create ANK-101, a stable complex that combines a modified IL-12 cytokine with an FDA-approved adjuvant, aluminum hydroxide, which helps to retain the cytokine's potent activity at the tumor site. This localized delivery results in targeted inflammation that activates an anti-tumor immune response while minimizing adverse effects. Ankyra aims to optimize the efficacy and safety of its therapies, ultimately improving treatment outcomes for cancer patients.

Infinitus Systems automates phone calls in healthcare using AI. It streamlines administrative tasks like insurance eligibility checks, improving efficiency, reducing costs, and enhancing patient care.

Signos is a health technology company focused on addressing the obesity epidemic by promoting healthy habits and stabilizing glucose levels through innovative solutions. The company offers a weight loss application that leverages continuous glucose monitoring in conjunction with an AI-enhanced platform. This combination provides users with real-time data and personalized recommendations for meals and exercises tailored to their unique metabolic responses. By enabling individuals to better understand their body's reactions to food, Signos aims to facilitate effective weight loss and foster sustainable health improvements. With a significant portion of the American population facing weight-related challenges, Signos presents a modern approach to support users on their journey towards healthier living.

Cambridge Epigenetix Limited is a bioscience company based in Babraham, United Kingdom, specializing in epigenetic tools that aim to transform medical diagnostics. Founded in 2012 as a spin-out from the University of Cambridge, the company is pioneering the clinical applications of epigenetics, particularly through its innovative TrueMethyl technology. This includes oxidative bisulfite sequencing, which allows for the precise sequencing of hydroxymethyl cytosine and methylcytosine at single-base resolution. Cambridge Epigenetix offers a range of products, such as TrueMethyl 6 and TrueMethyl 24 kits, designed for the quantitative measurement and analysis of these critical epigenetic markers. The company’s research highlights the significance of 5-hydroxymethylcytosine as a biomarker for various diseases, including colorectal cancer, and aims to simplify diagnostic processes to a simple blood draw. The firm collaborates with third-party vendors and sells its products directly to business customers both in the UK and internationally.

Patina is a healthcare company reinventing primary care for older adults by delivering a human, personalized, on-demand care model designed to improve the healthcare and aging experience for seniors and their families. The approach centers on the specific needs and values of aging individuals, offering flexible access to care and enabling families and loved ones to participate as part of the care team. By focusing on dignity in aging and a coordinated, person-centered experience, Patina aims to align medical care with daily living and the goals of aging adults.

Sprinter Health is a mobile healthcare provider that sends full-time nurses and phlebotomists to patients' homes for preventive care services.

Medsaf operates an end-to-end pharmaceutical procurement and distribution platform in Nigeria that connects hospitals, pharmacies, and patients to affordable, quality medications with timely delivery. The platform combines an online marketplace with blockchain-backed track-and-trace, data analytics, and embedded financing to improve efficiency, safety, and transparency across the pharmaceutical supply chain. It provides quality-control as a service and links manufacturers, vetted suppliers, and logistics providers to health-care buyers, enabling automated procurement and financing options, including buy-now-pay-later for medication procurement. Based in Lagos, the company aims to streamline procurement, enhance visibility into the movement of medicines, and ensure reliable access to medications for health-care providers and consumers.

ROME Therapeutics, Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on developing innovative therapies for cancer and autoimmune diseases. Founded in 2019, the company utilizes the repeatome, which encompasses extensive segments of genetic material previously regarded as "junk DNA," to identify new drug targets and advance multiple discovery programs. ROME Therapeutics has assembled a team of experts in oncology, immunology, virology, and machine learning to drive its research and development efforts, aiming to harness this uncharted area of biology for effective treatments. Through its work, ROME seeks to provide healthcare professionals with powerful new options for addressing complex medical challenges.

Genome Medical operates a platform that connects individuals and healthcare providers with genetic specialists. It offers virtual genetic care services, including clinical consultations for various health areas like cancer, cardiology, and reproductive health. The company uses its Genome Care Delivery technology to facilitate efficient genetic assessments and personalized treatment plans.

Ultromics Limited, founded in 2017 and based in Oxford, United Kingdom, specializes in developing advanced echocardiography software aimed at enhancing the diagnosis of coronary heart disease. By leveraging artificial intelligence, the company has created highly accurate diagnostic tools that improve the identification of coronary artery disease, achieving diagnostic accuracy improvements of over 90%. Ultromics' technology processes complex data from electrocardiograms, empowering healthcare providers to make informed clinical decisions and ultimately enhancing patient care in cardiology.

Nym Health Inc., established in 2017 and headquartered in Boston, Massachusetts, specializes in medical coding technology for healthcare facilities. Its core product, Nym, is an autonomous coding solution that streamlines revenue cycle management. Nym reduces denials and operational expenses by directly billing and accurately assigning medical charge codes from patient charts, improving payment cycles and audit-readiness. It identifies relevant clinical aspects, assigns codes, and provides an audit trail explaining its coding decisions. With a research and development center in Tel Aviv-Yafo, Israel, Nym enables healthcare providers to enhance coding quality, lower costs, and focus more on patient care.